CONSHOHOCKEN, PA — Cencora, formerly known as AmerisourceBergen, is setting a new industry standard with its latest Environmental, Social, and Governance (ESG) and Diversity, Equity, and Inclusion (DEI) Reports. These in-depth studies analyze Cencora’s performance and its robust commitment to operations that serve both our planet and people as a whole.
For six back-to-back years, select information contained in these reports has been examined and confirmed by external third-party verifier, ERM Certification and Verification Services. This not only ensures transparency but also boosts the reliability of the data provided.
Cencora’s ESG approach mirrors its mandate and responsibility to facilitate healthier futures. Its pivotal role in the global pharmaceutical value chain positions it perfectly to champion key priorities, supporting purpose-driven team members, promoting resilient and sustainable operations, and empowering healthy customers and communities.
Cencora’s ESG plan revolves around three vital priorities:
Priority one involves putting people first. They cultivate a diverse and inclusive workspace by actively collaborating and adhering to the highest of ethical and compliance standards. Highlights include advancing inclusion, taking care of team members, and investing in Employee Resource Groups.
Priority two focuses on resilient and sustainable operations. They aim to ensure accessible medications for people and animals, while safeguarding the health of our planet. Highlights here include climate and energy management, waste management, recycling and sustainable packaging, and supplier diversity.
The final priority is geared towards healthy customers and communities. By expanding access to quality healthcare, Cencora is making strides in improving health outcomes in communities and with customers globally. Highlights include the establishment of the Cencora Impact Foundation, responding to global crises, expanding access to healthcare, and fostering innovation.
Cencora has etched its name into the S&P Global Sustainability Yearbook 2024, being part of the top 15% in their industry. Moreover, it has scored within 30% of their industry’s highest-performing company in the S&P Global 2023 Corporate Sustainability Assessment (CSA).
In the fast-paced pharmaceutical industry, Cencora’s commitment to ESG and DEI establishes a new benchmark. As it continues to evolve, other industry players will be watching closely, potentially ushering in a new era of sustainable and inclusive practices.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.